Navigation Links
deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke
Date:7/13/2009

in the genome (SNPs) conferring increased risk of major public health challenges from cardiovascular disease to cancer. Based upon these discoveries deCODE has brought to market a growing range of DNA-based tests for gauging risk and empowering prevention of common diseases. Through its CLIA-registered laboratory, deCODE offers deCODE T2(TM) for type 2 diabetes; deCODE AF(TM) for atrial fibrillation and stroke; deCODE MI(TM) for heart attack; deCODE ProstateCancer(TM) for prostate cancer; deCODE Glaucoma(TM) for a major type of glaucoma; and deCODE BreastCancer, for the common forms of breast cancer. Its lead therapeutic programs, which leverage the company's expertise in chemistry and structural biology, include DG041, an antiplatelet compound being developed for the prevention of arterial thrombosis; DG051 and DG031, compounds targeting the leukotriene pathway for the prevention of heart attack; and DG071 and a platform for other PDE4 modulators with therapeutic applications in Alzheimer's disease and other conditions. deCODE is delivering on the promise of the new genetics(SM). Visit us on the web at http://www.decode.com; on our diagnostics site at http://www.decodediagnostics.com; for our pioneering personal genome analysis service and new focused disease scans, integrating the genetic variants included in these tests and those linked to another twenty common diseases, as well as for our new deCODEme Cardio(TM) and deCODEme Cancer(TM) scans, at http://www.decodeme.com; and on our blog at http://www.decodeyou.com.

Any statements contained in this presentation that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
'/>"/>

SOURCE DeCODE Genetics Inc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
2. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
3. deCODE Launches a DNA-Based Test for Assessing Risk of Prostate Cancer on the Back of the Discovery of New Prostate Cancer Genes
4. deCODE Obesity Study Sheds Light on How Genetics Affects Risk and Onset of Common Diseases
5. deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer
6. Marketing of Diagnostics and deCODEme(TM), Recent Progress in Drug Development to be Highlighted at deCODE R&D Event
7. deCODE and SGENE Consortium Discover Deletions in the Human Genome Linked to Risk of Schizophrenia
8. deCODE and Radboud University Discover Common Variants in the Human Genome Conferring Risk of Bladder Cancer
9. deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimers and Other Cognitive Disorders
10. Major deCODE-led Study Underscores Role of the Brain in Obesity
11. A Milestone in Cancer Genetics: deCODE Discovers First Common Genetic Variants Affecting the Risk of Many Types of Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015  Following a ... Committee that moved H.R. 284, the Medicare DMEPOS ... American Association for Homecare (AAHomecare) released a statement ... action to pass the legislation. "Today,s ... the House Ways and Means Committee is a ...
(Date:2/27/2015)... 27, 2015 An aggressive campaign to reduce ... rate of infection with a dangerous drug-resistant bacteria at ... Clostridium difficile, or C.diff, is a bacterium that can ... the colon. A recent article in the New England ... in the United States " asserts ...
(Date:2/27/2015)... Feb. 27, 2015 /CNW/ - Covalon Technologies Ltd. (the "Company" ... today announced financial results for its first quarter ended ... months ended December 31, 2014, revenue was $1,336,685. Operating ... $229,820 or $0.02 per share.  Covalon,s ... am very pleased with the significant progress we have ...
Breaking Medicine Technology:Bidding Fix Takes Major Step Forward After Bipartisan Vote of House Ways and Means Committee 2Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 2Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 3Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3
... Corporation (NYSE: CBM ) announced today that it ... based pharmaceutical company focused on the formulation of final dosage ... To be named Cambrex Zenara Positions Cambrex ... and growing Nicotine Replacement Therapy ("NRT") market providing both active ...
... 2, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var s = ,; var first_result; // Results are keyed by longUrl, so we need to grab the first ...
Cached Medicine Technology:Cambrex Acquires Stake in Zenara Pharma 2Cambrex Acquires Stake in Zenara Pharma 3Cambrex Acquires Stake in Zenara Pharma 4Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 2Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 3Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 4Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 5Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 6Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 7Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 8Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 9
(Date:2/28/2015)... (PRWEB) February 28, 2015 March—also ... good time to remind ourselves and others that ... say Atlantic NeuroSurgical Specialists (ANS). , Concussions are ... account for 75% of TBIs. There are 1.6-3.8 ... may sound benign, but it is a brain ...
(Date:2/28/2015)... 2015 Indosoft Inc , developers ... Asterisk, are pleased to announce the development of Q-Suite ... 5.8 versions of Q-Suite, this new version will include ... of new features to the leading edge call center ... 5.9 will add features to enhance security and protection. ...
(Date:2/28/2015)... 28, 2015 The Mesothelioma Applied ... awards at the International Symposium on Malignant Mesothelioma on ... at the Hyatt Regency Bethesda in Bethesda, Maryland. The ... work and commitment to the mission to cure mesothelioma. ... will be presented to Miriam Ratner. Miriam runs the ...
(Date:2/28/2015)... Dr. Perry Patel , a ... recently announced a special offer for the Zoom!® Chairside ... for new and established patients at his Pismo Beach dentist office. ... white smile, Dr. Patel and his staff are offering ... from the regular price of $450. , Zoom! whitening ...
(Date:2/28/2015)... Kaylie Corrigan, Outdoor Supervisor at ... and current student obtaining her Masters degree in social ... forum in psychoeducation on substance use for teens at ... part of her studies. , “Even though these students ... counseling at the high school and junior high school ...
Breaking Medicine News(10 mins):Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3Health News:Indosoft Proudly Announces Q-Suite 5.9 Call Center Software for Asterisk 2Health News:Cancer Research Foundation Honors Award Recipients 2Health News:Cancer Research Foundation Honors Award Recipients 3Health News:Cancer Research Foundation Honors Award Recipients 4Health News:Pismo Beach Dentist Announces Special for Zoom! Teeth Whitening 2Health News:Staff at Arizona Drug Addiction Treatment Center Starts Teen Sobriety Support Group at Local High School 2
... the University of California, San Francisco (UCSF) Medical Center has ... as healthy brain cells begin to form tumors. The ... common type of brain tumor, at its earliest stage, when ... have to prove safe and effective in clinical trials, a ...
... of an oral tablet or vaginal gel containing antiretroviral ... modified because an interim review found that the study ... tenofovir, marketed under the trade name Viread, is effective., ... that the Vaginal and Oral Interventions to Control the ...
... HealthDay Reporter , TUESDAY, Sept. 27 (HealthDay News) ... doesn,t slow decline in thinking skills, a new study ... study participants, risk of death, the researchers found. ... twice as likely to suffer mental impairment as those ...
... LAFAYETTE, Ind. - Purdue University scientists believe they have found ... Xiaoqi Liu, an assistant professor of biochemistry and member ... Liu are focusing on the function of a gene called ... Plk1 is also an oncogene, which tends to mutate and ...
... diagnostic test for Alzheimer,s disease (AD), scientists have discovered that ... of a protein linked to pregnancy years before showing symptoms. ... Theo Luider and colleagues explain that more than ... are rising with the graying of the population. Doctors can ...
... Breast cancer cells that mutate to resist drug treatment ... the drugs as they penetrate the cell membrane making ... Researchers have found a new way to break that ... breast cancer cells to forcibly activate a heat-shock protein called ...
Cached Medicine News:Health News:How normal cells become brain cancers 2Health News:NIH modifies 'VOICE' HIV prevention study in women 2Health News:Super-Tight Blood Sugar Control May Not Ease Mental Decline in Diabetics 2Health News:Super-Tight Blood Sugar Control May Not Ease Mental Decline in Diabetics 3Health News:Gene may be good target for tough-to-kill prostate cancer cells 2Health News:Scientists shut down pump action to break breast cancer cells' drug resistance 2Health News:Scientists shut down pump action to break breast cancer cells' drug resistance 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: